{"filing":{"accession_number":"0000064803-26-000097","cik":"0000064803","ticker":"CVS","company_name":"CVS HEALTH Corp","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"cvs-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000097/cvs-20260805.htm"},"events":[{"id":24306,"run_id":22011,"accession_number":"0000064803-26-000097","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"CVS Health issued a press release on August 5, 2026 announcing second quarter 2026 results for the three months ended June 30, 2026, disclosing total revenues of $106.1 billion (up 7.3% YoY), diluted EPS of $2.31, and adjusted EPS of $2.58, along with raised full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 and attached as Exhibit 99.1.","company_name":"CVS HEALTH Corp","ticker":"CVS","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24812,"accession_number":"0000064803-26-000097","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"CVS Health issued a press release on August 5, 2026 announcing second quarter 2026 results for the three months ended June 30, 2026, disclosing total revenues of $106.1 billion (up 7.3% YoY), diluted EPS of $2.31, and adjusted EPS of $2.58, along with raised full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 and attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:20:53.856643+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24812,"accession_number":"0000064803-26-000097","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"CVS Health issued a press release on August 5, 2026 announcing second quarter 2026 results for the three months ended June 30, 2026, disclosing total revenues of $106.1 billion (up 7.3% YoY), diluted EPS of $2.31, and adjusted EPS of $2.58, along with raised full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 and attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:20:53.856643+00:00","company_name":"CVS HEALTH Corp","ticker":"CVS","filing_date":"2026-08-05"}]}